<DOC>
	<DOCNO>NCT01800825</DOCNO>
	<brief_summary>Preterm birth link certain type vaginal infection . The goal study determine give woman pregnant 13-20 week elavated vaginal pH ( evidence type infection ) Oral Clindamycin ( antibiotic ) low rate preterm birth compare woman give placebo ( starch )</brief_summary>
	<brief_title>Clindamycin Reduce Preterm Birth Low Resource Setting</brief_title>
	<detailed_description>The primary study objective definitively test whether 300 mg oral clindamycin two time per day 5-days administer 13-20 week gestation woman vaginal pH≥5 reduces incidence preterm delivery Karnataka , India least 30 % . The national incidence gestation &lt; 37 week India 14.5 % , 18 % study area 2011 20 % among woman vaginal pH≥5 recently complete Jawaharlal Nehru Medical Collage ( JNMC ) hospital-based study clindamycin reduce preterm birth . Using two tailed test , α=0.05 , 1-β=80 % , 17.5 % rate prematurity woman vaginal pH≥5 , 2.5 % refusal 7.5 % loss follow-up , assume 86 % woman present antenatal care 13-20 week gestation 1 % otherwise ineligible , multiple comparison adjustment , 1,726 woman , half clindamycin half placebo group , need enrol test primary hypothesis . The effect clindamycin spontaneous preterm birth , miscarriage , low birthweight ( LBW ) , neonatal mortality ( NMR ) , maternal neonatal complication 42 day postpartum , utility vaginal pH≥5 identify woman risk preterm delivery cost preterm birth prevent oral clindamycin treatment compliance 5-day treatment regimen also assess . This first investigation test whether oral clindamycin prevents preterm birth community-based , develop country setting , global newborn death occur .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<criteria>Women singleton Intrauterine pregnancy 1320 week Maternal age 18 old &lt; 18 assent woman 's parent/guardian Vaginal PH &gt; 5.0 Use antibiotic within 14 day prior randomization Known sensitivity antibiotic Uterine anomaly Major fetal anomaly Medical condition may result iatrogenic prematurity ( e.g.diabetes , Lupus , Hypertension )</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Prematurity</keyword>
	<keyword>Preterm birth</keyword>
	<keyword>bacterial vaginosis</keyword>
</DOC>